Pharmacokinetics, Tolerability and Safety of NEX-18a

Clinical trial NCT05048498 · COMPLETED

Trial details

NCT number: NCT05048498
Sponsor: Nanexa AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndromes (MDS)Chronic Myelomonocytic Leukemia (CMML)Acute Myeloid Leukemia (AML)

Start date: 2021-04-27
Primary completion: 2022-02-10
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.